Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure doesn’t act like a CEO with a revolutionary pill.
Probably will have the same “it’s my job” attitude when the co is worth 5,10,15, BILLION.
Well, I’m in my low 40s but would most definitely take Blarcamesine as a preventative.
I don’t think Missling is in any rush to get AVXL higher. He’ll let the trial results speak for themself. 3 trial readouts,2 of which are BIG Potential, within the next 365 days…..?
I’m glad I was able to still gather another 1500 shares over the last 2 trading days.
Tom, I think some people like to play Sunday Quarterback and select their “sell” and “buy” after the fact.
It shows ones true character when another company got you beat. They still discount said company for what they accomplished because you couldn’t do it the last 20 years.
At least we know how soon SAVA will complete enrollment of their Alz trial. KINDA SOON. So really really….not soon at all.
That would be irresponsible of him to do, so unless verified, I call BS.
Much Lawsuits if denied.
How about if the trial being pivotal possibly being at risk
If the FDA could be influenced to approve a bad drug, no doubt that influence could also be used to find an excuse.
None of that came out from my account.
I do believe thou will go the way of Pluto however.
How much does he still hold?
Majority of CEOs get awarded the same way for hitting milestones.
I hope everyone on this board lives to see THAT day.
Especially my friends that never listened to me to purchase when we were in the $2-$5 range earlier this year.
20 > 150 is 750%
20 > 1000 is 5,000 %
I’ll take staying independent over 150 ea ANY day
The multiples are ludicrous here.
This isn’t a get rich quick scheme. Buyouts are for suckers, and Missling will hopefully see this through across the finish line. He’ll deserve a Time magazine man of the year for the life changing “pill” he will have brought to market.
Not sure what math you are doing but $150 is NOT $300. AVXL could easily be $500+ within 5 years.
Yup, that’s why he’s even starting a trial, P3, as a preventative treatment. Biogen thinks their “drug” can achieve that, Anavex certainly can do it better AND safer.
Both as a simple pill AND with patient safety in mind.
All about signals now that you look at it.
He never sold before. Sold some after pd data since no news for at least 60 days…possibly for Rett news
Bought back as a hey…..we got this. See what I’m doing…. Same thing as I did a few times over the years.
Then again, probably no news for a while again.
P2/3 read out will wake some people. Until then…. Accumulate
Some people think of themselves too much.
I don’t believe we will see a peek either.
If it risks getting the drug to patients even 6 months later, I don’t see why he would risk that.
Approval for Rett and/or Parkinson’s could possibly already allow for off label prescription.
Speaking of, I’m getting to that age of taking it as a preventative.
You peer review when you WANT people to understand what you are doing.
You DON’T peer review when you are for sale, or trying to pull the sheet over ones eyes.
Don’t take advice from a puppet.
Old wise saying I heard once.
As if Rett and Parkinson’s trial data wasn’t an over deliver on results.
Lol. That’s why you aren’t a CEO and he is.
He is going after the same thing that BIIB is targeting. Plaque. They remove them, we prevent them from even being created. THEY will be of no use once we are taken as a preventative.
Plus all of those “OTHER” effects that Blarcamesine may potentially achieve.
Warning: you may get a slight headache as a side effect.
That was the best hype money could buy. Even I was seriously considering riding the wave up and selling before the crash but decided against it.
Lines up perfectly with what research shows as a long term effect of having been through covid.
That PR yesterday was Missling letting BIIB know we are gonna steal your lunch money.
How significant it is to go from talking about mice studies to P3 in the same paragraph.
Speaking of…. Let’s revisit that millionaires list now.
Who here WAS a millionaire.
It’s a perfect counter to BIIB 10 year trial.
??We can do what you can do, we can do it better….we can do anything better than you??
Funny thing about AVXL. It is no longer PR happy. When something is relevant to the science/co, it will announce something then crouch back into its comfortable spot.
Now, we are in that comfortable spot waiting for the next relevant scientific/co announcement.
And it’s not so bad…..sure beats us being in the $5 range waiting for anything relevant.
Others may be momentarily above us price wise, but we shall see who comes out scientifically. THAT, wins the war!!
Wouldn’t it be better for the body to make vs rely on it being introduced?
In other words….. a low guess. I’ll raise your 25 and add 50% more.
Reason? mRNA from within the body vs introduced
You see BIIB pull their paper from Jama because they demanded edits be made?
“Biogen pulled Aduhelm paper after JAMA demanded edits”
Poor guys can’t even get that FIIB peer reviewed correctly
https://www.yahoo.com/news/biogen-pulled-aduhelm-paper-jama-163654140.html
It’s like watching kindergarteners paint.
I guess you want the summary to be SAVA is best cause it was the most recommended?
One day we will look back and say see, the cramers and Adams of the world really were puppets. Until then…..
We know why they NEVER mention Anavex
Unless they plan to…
I’ll bet against your hedge.
If A-273 is already approved for Rett and possibly PDD with no serious side effects among all trials…,.
Didn’t Missling attend a conference about basket trials/master protocols?
A Basket Trial involves a single investigational drug or drug combination that is studied across multiple
cancer populations defined by disease stage, histology, number of prior therapies, genetic or other
biomarkers, or demographic characteristics. It is usually designed as a single-arm, activity-estimating
trial with overall response rate as the primary endpoint. A strong response signal seen in a sub-study
may allow for expansion to generate data that could potentially support a marketing approval.
https://www.fda.gov/media/125556/download
As much as we’d all hope, I doubt it. The goal is either of the following:
1. Frustrate retail and drive them out of the stock.
2. Have retail sell for minimal gains before the real spike starts.
Fortunately, time is on our side as we know the clock has already started counting down.
Alzheimer’s alone gets us WAY pass $110
Oh no…..according to a 6 question quiz, I need to talk to my local Alzheimer’s Dr. about getting screened. I may be in the beginning stages of Alzheimer’s……
That 6 question quiz brought to you by non other than the people that will offer you a 56k fake treatment.
https://www.itstimeweknow.com/en_us/home/what-is-mild-cognitive.html
Yes. They are the perfect example of a law being a slap on the wrist. What’s 5,10,15% of your profit paying for a fine.
That sure teaches them to never do it again.
Sure, I’m so angry that I’m still up over 800%……
I’m so angry I think I’ll hold for another couple years.
Seems like when there’s nothing else to discuss, patent becomes an issue, only to not become one a week or two later.
This must be the 3rd time it has been attempted. Good ol Plato…..what ever happened to that guy….
If anyone gets down on where the current SP is, all one has to do is look at the July Anavex presentation and realize where this stock could potentially go. Doesn’t matter if the current pps don’t reflect the explosiveness it could have. As long as things are progressing, the SP will take care of itself in due time.
https://www.anavex.com/wp-content/uploads/2021/07/Anavex-Presentation-July-2021.pdf